“I would like to suggest a “long strangle” strategy for the budget, though it will be risky given the high premiums of the options. Besides, after a few days of consolidation, Nifty looks good for a directional move,” says Rupak De, Senior Technical Analyst at . In an interview with ETMarkets, Rupak said: “Nifty could … Read more
“The trend is actually like you said neutral or it is more towards sell on rise because for any sort of upside trend change, we will see that Nifty has to close above 18,250 in future,” says Shilpa Rout, Prabhudas Lilladher.A view on the market after yesterday’s so called selloff led by FII selling. What … Read more
Global brokerage firm Goldman Sachs maintained a buy rating on M&M, while Credit Suisse retained Underperform on . At the same time, Jefferies maintained hold on SRF and JPMorgan neutral on . We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Goldman Sachs on M&M: Buy| Target Rs … Read more
Indian market started on a strong note on Friday, tracking positive global cues. The S&P BSE Sensex rallied nearly 300 points while Nifty50 reclaimed 16,000 levels in the first 15 minutes of trade. The rupee hit a fresh record low for the 5th day as it touched 79.94 against the US dollar. Sectorally, buying was … Read more
Technical and derivative analysts expect the Nifty to rise further in the coming week, up to 16,000 levels. The Nifty gained 2.7% last week to 15,699.25, outperforming most of the Asian peers. SUDEEP SHAH HEAD, TECHNICAL & DERIVATIVES RESEARCH, SECURITIES What should investors/traders do? Investors should look to buy the dips until 15,450 levels are … Read more
Nifty futures on the Singapore Exchange traded 181 points, or 1.03 per cent lower at 17,425, signaling that Dalal Street was headed for a negative start on Friday. Here are a dozen stocks which may buzz the most in today’s trade: ONGC, Divi’s Labs, Apollo Hospitals: Oil and Natural Gas Corporation, Divis Laboratories, Apollo Hospitals, … Read more
MUMBAI: Before you jump to conclusions, no it’s not because some investors are predicting the third wave of the pandemic to hit us very soon. While the surge in shares of oxygen suppliers like and may not indicate that a third wave is coming soon, the move is related to the preparation towards that eventuality. … Read more